Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Scherlinger

Showing results (41-50 of 72) with videos related to

Pageof 8
Sort By:
Joint Bone Spine|November 21, 2017
Switching from originator infliximab to biosimilar CT-P13 in real-life: The weight of patient acceptanceMarc Scherlinger, Vincent Germain, Céline Labadie, et al.
Autoimmunity Reviews|April 11, 2018
Systemic lupus erythematosus and systemic sclerosis: All roads lead to plateletsMarc Scherlinger, Vivien Guillotin, Marie-Elise Truchetet, et al.
Annals of the Rheumatic Diseases|January 6, 2019
Rituximab in moderate to severe non-renal systemic lupus erythematosus: a reanalysis of the EXPLORER studyMarc Scherlinger, Claire Carcaud, Marie-Elise Truchetet, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 7, 2022
Role of Glutaminase 2 in Promoting CD4+ T Cell Production of Interleukin-2 by Supporting Antioxidant Defense in Systemic Lupus ErythematosusRyo Hisada, Nobuya Yoshida, Seo Yeon K Orite, et al.
Rheumatology (Oxford, England)|March 16, 2026
Acute myocarditis after switching between two adalimumab biosimilarsThomas Subervie, François Sauer, Jean-Jacques Von Hunolstein, et al.
Nature Communications|January 29, 2024
CaMK4 controls follicular helper T cell expansion and function during normal and autoimmune T-dependent B cell responsesMarc Scherlinger, Hao Li, Wenliang Pan, et al.
Rheumatology (Oxford, England)|December 9, 2023
Combining ts- and a bDMARD in refractory rheumatoid arthritis: an unusual adverse eventCédric Sztejkowski, Jean Sibilia, François Danion, et al.
Science Advances|November 30, 2022
Phosphofructokinase P fine-tunes T regulatory cell metabolism, function, and stability in systemic autoimmunityMarc Scherlinger, Wenliang Pan, Ryo Hisada, et al.
Cellular & Molecular Immunology|May 6, 2022
The deacetylase SIRT2 contributes to autoimmune disease pathogenesis by modulating IL-17A and IL-2 transcriptionRyo Hisada, Nobuya Yoshida, Masataka Umeda, et al.
Rheumatology (Oxford, England)|June 14, 2020
Role of stress in the development of rheumatoid arthritis: a case-control studyVincent Germain, Marc Scherlinger, Thomas Barnetche, et al.
Pageof 8

Showing results (41-50 of 72) with videos related to

Sort By:
Pageof 8
Joint Bone Spine|November 21, 2017
Switching from originator infliximab to biosimilar CT-P13 in real-life: The weight of patient acceptanceMarc Scherlinger, Vincent Germain, Céline Labadie, et al.
Autoimmunity Reviews|April 11, 2018
Systemic lupus erythematosus and systemic sclerosis: All roads lead to plateletsMarc Scherlinger, Vivien Guillotin, Marie-Elise Truchetet, et al.
Annals of the Rheumatic Diseases|January 6, 2019
Rituximab in moderate to severe non-renal systemic lupus erythematosus: a reanalysis of the EXPLORER studyMarc Scherlinger, Claire Carcaud, Marie-Elise Truchetet, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 7, 2022
Role of Glutaminase 2 in Promoting CD4+ T Cell Production of Interleukin-2 by Supporting Antioxidant Defense in Systemic Lupus ErythematosusRyo Hisada, Nobuya Yoshida, Seo Yeon K Orite, et al.
Rheumatology (Oxford, England)|March 16, 2026
Acute myocarditis after switching between two adalimumab biosimilarsThomas Subervie, François Sauer, Jean-Jacques Von Hunolstein, et al.
Nature Communications|January 29, 2024
CaMK4 controls follicular helper T cell expansion and function during normal and autoimmune T-dependent B cell responsesMarc Scherlinger, Hao Li, Wenliang Pan, et al.
Rheumatology (Oxford, England)|December 9, 2023
Combining ts- and a bDMARD in refractory rheumatoid arthritis: an unusual adverse eventCédric Sztejkowski, Jean Sibilia, François Danion, et al.
Science Advances|November 30, 2022
Phosphofructokinase P fine-tunes T regulatory cell metabolism, function, and stability in systemic autoimmunityMarc Scherlinger, Wenliang Pan, Ryo Hisada, et al.
Cellular & Molecular Immunology|May 6, 2022
The deacetylase SIRT2 contributes to autoimmune disease pathogenesis by modulating IL-17A and IL-2 transcriptionRyo Hisada, Nobuya Yoshida, Masataka Umeda, et al.
Rheumatology (Oxford, England)|June 14, 2020
Role of stress in the development of rheumatoid arthritis: a case-control studyVincent Germain, Marc Scherlinger, Thomas Barnetche, et al.
Pageof 8